|
Re: PharmaCyte Biotech seems to be our main competition...
|
5
|
Resverlogix Corp.
|
Apr 05, 2017 11:34AM
|
|
Re: Pfizer's plans for research: sounds like RVX!
|
3
|
Resverlogix Corp.
|
Jan 29, 2020 04:29PM
|
|
Re: Pfizer's patent application and a potential Priority Review Voucher?
|
6
|
Resverlogix Corp.
|
May 23, 2017 10:12AM
|
|
Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
|
7
|
Resverlogix Corp.
|
Jun 30, 2019 02:47AM
|
|
Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
|
2
|
Resverlogix Corp.
|
Jun 30, 2019 02:47PM
|
|
Re: Pfizer sees strong demand for COVID pill as profits surge.
|
7
|
Resverlogix Corp.
|
May 04, 2022 02:05PM
|
|
Re: Pfizer sees strong demand for COVID pill as profits surge.
|
4
|
Resverlogix Corp.
|
May 04, 2022 09:34PM
|
|
Re: Pfizer sees strong demand for COVID pill as profits surge.
|
4
|
Resverlogix Corp.
|
May 05, 2022 12:30AM
|
|
Re: Pfizer seems like a good fit for a BP deal
|
2
|
Zenith Epigenetics
|
Jan 10, 2024 02:32PM
|
|
Re: Pfizer seems like a good fit for a BP deal
|
3
|
Zenith Epigenetics
|
Jan 09, 2024 10:45AM
|
|
Re: Pfizer enzalutimide perspective
|
7
|
Zenith Epigenetics
|
May 16, 2017 03:44AM
|
|
Re: Pfizer enzalutimide perspective
|
|
Zenith Epigenetics
|
May 16, 2017 01:36PM
|
|
Re: Pfizer collaboration
|
4
|
Zenith Epigenetics
|
Jan 07, 2019 10:26AM
|
|
Re: pfizer
|
2
|
Resverlogix Corp.
|
Dec 15, 2020 07:18PM
|
|
Re: pfizer
|
6
|
Resverlogix Corp.
|
Dec 16, 2020 01:44PM
|
|
Re: Patient Enrollment Modeling
|
5
|
Resverlogix Corp.
|
Dec 02, 2018 12:58PM
|
|
Re: Pascal Soriot
|
3
|
Resverlogix Corp.
|
Jul 13, 2017 01:11AM
|
|
Re: Pascal Soriot
|
3
|
Resverlogix Corp.
|
Jul 13, 2017 11:36AM
|
|
Re: Partnership or Sale
|
5
|
Resverlogix Corp.
|
Feb 03, 2020 04:26PM
|
|
Re: Partnership or Sale
|
4
|
Resverlogix Corp.
|
Feb 03, 2020 11:14AM
|
